These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The importance of the monoamine oxidase inhibitors in cardiovascular disease. GRIFFITH GC. Am J Cardiol; 1960 Dec; 6():1103-5. PubMed ID: 13708592 [No Abstract] [Full Text] [Related]
3. The THERAPEUTIC action of monoamine oxidase inhibitors. Angiology; 1960 Feb; 11():55-7. PubMed ID: 13856617 [No Abstract] [Full Text] [Related]
4. Preliminary observations on the role of monoamine oxidase inhibitors in the therapy of peripheral arterial disease. SAMUELS SS, SHAFTEL HE. Angiology; 1960 Feb; 11():90-2. PubMed ID: 14441293 [No Abstract] [Full Text] [Related]
6. Monoamine oxidase inhibitors in the treatment of angina pectoris. RUSSEK HI. Angiology; 1960 Feb; 11():76-80. PubMed ID: 14440277 [No Abstract] [Full Text] [Related]
7. Coronary artery disease: the use of monoamine oxidase inhibitors in the treatment of the anginal syndrome. FRIEDGOOD CE. Angiology; 1960 Feb; 11():84-5. PubMed ID: 13825069 [No Abstract] [Full Text] [Related]
8. On the mechanism of action of monoamine oxidase inhibitors in angina pectoris. PLETSCHER A, GEY KF. J Am Geriatr Soc; 1961 Jun; 9():410-8. PubMed ID: 13736338 [No Abstract] [Full Text] [Related]
9. Experiences in the treatment of angina pectoris with monoamine oxidase inhibitors. OBLATH RW, GRIFFITH GC. J Am Geriatr Soc; 1961 Jun; 9():427-31. PubMed ID: 13730182 [No Abstract] [Full Text] [Related]
10. [Study of the action of the isopropylhydrazide of p-chlorophenoxyacetic acid (P.C. 603), a new monoamine oxidase inhibitor, in depressive states]. BORENSTEIN P, DABBAH M, KRAMARZ P, HENON C. Ann Med Psychol (Paris); 1961 Oct; 119(2)():554-65. PubMed ID: 13871268 [No Abstract] [Full Text] [Related]
11. A comparative trial of four monoamine oxidase inhibitors on chronic depressives. BATES TJ, DOUGLAS AD. J Ment Sci; 1961 May; 107():538-46. PubMed ID: 13687739 [No Abstract] [Full Text] [Related]
12. A report on the effects of phenelzine (nardil), a monoamine oxidase inhibitor, in depressed patients. MIDDLEFELL R, FROST I, EGAN GP, EATON H. J Ment Sci; 1960 Oct; 106():1533-8. PubMed ID: 13770370 [No Abstract] [Full Text] [Related]
13. Clinical application of the monoamine oxidase inhibitors in cardiovascular disease. GRIFFITH GC. Dis Nerv Syst; 1960 Mar; 21(3)Suppl():101-3. PubMed ID: 13829305 [No Abstract] [Full Text] [Related]
14. Tersavid (RO 4-1634), an amine oxidase inhibitor, for the treatment of angina pectoris. Up to 15 months follow-up study. WEISMAN SJ, WEISMAN SA. Dis Chest; 1961 Apr; 39():459-63. PubMed ID: 13784031 [No Abstract] [Full Text] [Related]
15. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor. ARAI A. Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948 [No Abstract] [Full Text] [Related]
16. Indications, contraindications and treatment with monoamine oxidase inhibiting antidepressant drugs. SAINZ A. Angiology; 1960 Feb; 11():94-8. PubMed ID: 14440834 [No Abstract] [Full Text] [Related]
17. [Use of a monoamine oxidase inhibiting hydrazide, isocarboxazide for the treatment of mental depression]. RISER M, GAYRAL L, HURON R, TURNIN J, CARRIE J. Toulouse Med; 1960 Oct; 61():707-13. PubMed ID: 13741834 [No Abstract] [Full Text] [Related]
18. Monoamine oxidase inhibitors. II. Some amino and dialkylaminobenzyl hydrazines and their acyl derivatives. GARDNER TS, WENIS E, LEE J. J Med Pharm Chem; 1961 Mar 01; 3():241-52. PubMed ID: 13896916 [No Abstract] [Full Text] [Related]
19. Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines. GARDNER TS, WENIS E, LEE J. J Med Pharm Chem; 1960 Apr 01; 2():133-45. PubMed ID: 13826540 [No Abstract] [Full Text] [Related]
20. The pharmacological evaluation of monoamine oxidase inhibitors. LESSIN AW. Biochem Pharmacol; 1959 Nov 01; 2():290-8. PubMed ID: 14416030 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]